- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Charming Medical Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Mi | Nasdaq halts trading of Charming Medical after SEC suspension | 1 | Investing.com | ||
| Mi | Nasdaq, Inc.: Nasdaq Halts Charming Medical Limited | 4 | GlobeNewswire (USA) | ||
| 13.11. | Charming Medical Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| CHARMING MEDICAL Aktie jetzt für 0€ handeln | |||||
| 22.10. | Charming Medical Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 22.10. | Charming Medical completes $6.4 million IPO on Nasdaq | 3 | Investing.com | ||
| 22.10. | Charming Medical Limited Announces Closing of Initial Public Offering | 201 | PR Newswire | HONG KONG, Oct. 22, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired... ► Artikel lesen | |
| 21.10. | Charming Medical Prices IPO At $4 A Share | 771 | AFX News | WASHINGTON (dpa-AFX) - Charming Medical Limited (MCTA), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, announced the pricing of its initial... ► Artikel lesen | |
| 21.10. | Hong Kong wellness center operator Charming Medical prices US IPO at $4, the low end of the range | 2 | Renaissance Capital | ||
| 21.10. | Charming Medical prices IPO at $4 per share for NASDAQ listing | 2 | Investing.com | ||
| 21.10. | Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq | 298 | PR Newswire | HONG KONG, Oct. 21, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired... ► Artikel lesen | |
| 20.10. | Charming Medical Ltd - 8-A12B, Registration of securities | 1 | SEC Filings | ||
| 10.09. | Charming Medical Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 30.07. | Charming Medical Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 35,890 | 0,00 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| ALIGNMENT HEALTHCARE | 19,090 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 25,260 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| FRESENIUS | 46,490 | +0,26 % | Fresenius Launches Denosumab Biosimilars | ||
| PROCEPT BIOROBOTICS | 30,400 | -4,04 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 163,41 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PACS GROUP | 33,490 | 0,00 % | PACS Group, Inc. - 8-K, Current Report | ||
| FRESENIUS MEDICAL CARE | 40,630 | -0,20 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,450 | -0,33 % | PRESSESPIEGEL/Unternehmen: SIEMENS HEALTHINEERS, INSTONE, BÖRSE STUTTGART, VOLKSWAGEN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
SIEMENS HEALTHINEERS - Das größte Potenzial sieht Siemens-Healthineers-CEO... ► Artikel lesen | |
| BILLIONTOONE | 112,54 | -13,55 % | Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally | ||
| HEARTFLOW | 30,165 | 0,00 % | Heartflow, Inc.: Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform | MOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received... ► Artikel lesen | |
| RXSIGHT | 11,640 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,275 | -0,70 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| BETA BIONICS | 29,470 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CERIBELL | 16,680 | 0,00 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |
Das Unternehmen CHARMING MEDICAL LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,005 (-0,02 %) liegt der Kurs bei 29,350 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHARMING MEDICAL LIMITED finden Sie auf Wallstreet Online.